Document is current
Any future updates will be listed below
-
Authors
Andrade, Weslley S.
Tang, Fenny H. F.
Mariotti, Antonio C. H.
Mancini, Marilia W.
Duarte, Ivison X.
Singer, Eric A.
Weiss, Robert E.
Pasqualini, Renata
Arap, Wadih
Arap, Marco A.
-
Funding
Funding for this research was provided by:
Longenbaugh-Levy Donor-Advised Fund
- License Information
-
More Information
Article History
Received: 6 March 2023
Accepted: 25 May 2023
First Online: 7 June 2023
Competing interests
: M.W.M. is an employee of DMC Group, Brazil. However, other than technical advice and the gift of laser fibers, the DMC Group had no other role in the design, performance, data interpretation, writing and submission of this manuscript. E.A.S. is an advisory board of Johnson & Johnson, Merck, and Vyriad and receives research funding from Astellas/Medivation (all unrelated to submitted work). R.P and W.A are founders and equity stockholders of PhageNova Bio. R.P. is the Chief Scientific Officer and a paid consultant for PhageNova Bio. R.P. and W.A. are also founders and stockholders of MBrace Therapeutics; R.P. is a paid consultant and serves as a member of the board of directors for MBrace Therapeutics and W.A. is a member of the scientific advisory board. These relationships are all outside the scope of the submitted work and are managed in accordance with the established institutional conflict of interest policies of Rutgers, the State University of New Jersey. The other authors declare that they have no competing interests.
